Cargando…

Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV‐1 polyepitope CTL immunogen

This study is focusing on elucidation of the capacity of attenuated Salmonella enteritidis E23 (cya, crp) to serve as a vehicle for the rectal delivery of the DNA vaccine. Earlier for creation HIV‐1 candidate DNA vaccine we have designed the polyepitope protein TCI (T‐cell immunogen), which comprise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karpenko, Larisa I., Danilenko, Alexey V., Bazhan, Sergei I., Danilenko, Elena D., Sysoeva, Galina M., Kaplina, Olga N., Volkova, Olga Y., Oreshkova, Svetlana F., Ilyichev, Alexander A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815784/ https://www.ncbi.nlm.nih.gov/pubmed/21895998 http://dx.doi.org/10.1111/j.1751-7915.2011.00291.x

Ejemplares similares

In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice
por: Bazhan, Sergei I., et al.
Publicado: (2019)

Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in Mice
por: Bazhan, Sergei, et al.
Publicado: (2020)

P19-36. Preclinical study of CombiHIVvac vaccine
por: Kaplina, O, et al.
Publicado: (2009)

PolyCTLDesigner: a computational tool for constructing polyepitope T-cell antigens
por: Antonets, Denis V, et al.
Publicado: (2013)

Design and Evaluation of Optimized Artificial HIV-1 Poly-T Cell-Epitope Immunogens
por: Reguzova, Alena, et al.
Publicado: (2015)

Cationic Polymers for the Delivery of the Ebola DNA Vaccine Encoding Artificial T-Cell Immunogen
por: Karpenko, Larisa I., et al.
Publicado: (2020)

P17-02. PolyCTLDesigner: the software for constructing highly efficient polyepitope immunogens. Application to HIV-1
por: Antonets, D, et al.
Publicado: (2009)

Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope
por: Rudometov, Andrey P., et al.
Publicado: (2019)

Visualization of CombiHIVvac Vaccine Particles Using Electron Microscopy
por: Karpenko, Larisa I., et al.
Publicado: (2017)

Comparative analyses of the IV group oxides additives influence on the sintering kinetics of zirconia nanopowders
por: Lakusta, Marharyta, et al.
Publicado: (2018)

Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens
por: Starostina, Ekaterina V., et al.
Publicado: (2021)

P19-04. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins
por: Ilyichev, A, et al.
Publicado: (2009)

Influence of Obtaining Conditions on Kinetics of the Initial Sintering Stage of Zirconia Nanopowders
por: Lakusta, Marharyta, et al.
Publicado: (2016)

Immunogenicity evaluation of the HIV-1 Tat containing polyepitope DNA vaccine adjuvanted with CpG-ODNs in mice
por: Ollah Jazaeri, Ehsan, et al.
Publicado: (2021)

Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19
por: Borgoyakova, M. B., et al.
Publicado: (2023)

The development of Chinese specific human cytomegalovirus polyepitope recombinant vaccine
por: Zhao, Ping, et al.
Publicado: (2012)

Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022)

Development of Drugs Based on High-Polymeric Double-Stranded RNA for Antiviral and Antitumor Therapy
por: Danilenko, E. D., et al.
Publicado: (2019)

SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice
por: Volosnikova, Ekaterina A., et al.
Publicado: (2023)

TAA Polyepitope DNA-Based Vaccines: A Potential Tool for Cancer Therapy
por: Bei, Roberto, et al.
Publicado: (2010)

Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate
por: Karpenko, Larisa I., et al.
Publicado: (2021)

Design and expression of fusion protein consists of HBsAg and Polyepitope of HCV as an HCV potential vaccine
por: Gholizadeh, Monireh, et al.
Publicado: (2015)

The Effect of a Small Amount SiO(2) on Sintering Kinetics of Tetragonal Zirconia Nanopowders
por: Lakusta, Marharyta, et al.
Publicado: (2017)

Enhancing the Immunogenicity of Vaccinia Virus
por: Shchelkunov, Sergei N., et al.
Publicado: (2022)

The Structural and Immunological Properties of Chimeric Proteins Containing HIV-1 MPER Sites
por: Rudometov, A. P., et al.
Publicado: (2019)

Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
por: Li, Lijin, et al.
Publicado: (2021)

Chronic Fatigue Exhibits Heterogeneous Autoimmunity Characteristics Which Reflect Etiology
por: Danilenko, Olga V., et al.
Publicado: (2022)

Selection of Peptide Mimics of HIV-1 Epitope Recognized by Neutralizing Antibody VRC01
por: Chikaev, Anton N., et al.
Publicado: (2015)

The Natural Reservoirs of Salmonella Enteritidis in Populations of Wild Birds
por: Obukhovska, Olga
Publicado: (2013)

Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)

A minimal T-cell immunogen designed to cover HIV-1 specificities associated with control is immunogenic in mice and breaks CTL immunodominance
por: Mothe, B, et al.
Publicado: (2012)

A Novel Mineral-like Copper Phosphate Chloride with a Disordered Guest Structure: Crystal Chemistry and Magnetic Properties
por: Kiriukhina, Galina, et al.
Publicado: (2022)

Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Borgoyakova, M. B., et al.
Publicado: (2021)

Bright Light for Weight Loss: Results of a Controlled Crossover Trial
por: Danilenko, Konstantin V., et al.
Publicado: (2013)

Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response
por: Shcherbakov, D. N., et al.
Publicado: (2015)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
por: Ilyichev, A.A., et al.
Publicado: (2020)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Clinical EEG of Rett Syndrome: Group Analysis Supplemented with Longitudinal Case Report
por: Portnova, Galina, et al.
Publicado: (2022)

Objective Measures of Immediate “Energizing” Effect of Light: Studies Review and Data Analysis
por: Danilenko, Konstantin V.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i5dt7neugpga8136i41cbq4soa